0001593968-21-002287.txt : 20211021
0001593968-21-002287.hdr.sgml : 20211021
20211021171338
ACCESSION NUMBER: 0001593968-21-002287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20211021
DATE AS OF CHANGE: 20211021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOSTER ANDREW B
CENTRAL INDEX KEY: 0001285221
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36475
FILM NUMBER: 211337857
BUSINESS ADDRESS:
STREET 1: 440 CLYDE AVE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6509305282
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEMETIS, INC
CENTRAL INDEX KEY: 0000738214
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 261407544
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 408-517-3304
MAIL ADDRESS:
STREET 1: 20400 STEVENS CREEK BLVD
STREET 2: SUITE 700
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: AE BIOFUELS, INC.
DATE OF NAME CHANGE: 20110714
FORMER COMPANY:
FORMER CONFORMED NAME: AE Biofuels, Inc.
DATE OF NAME CHANGE: 20071212
FORMER COMPANY:
FORMER CONFORMED NAME: MARWICH II LTD
DATE OF NAME CHANGE: 19840123
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2021-01-25
0000738214
AEMETIS, INC
AMTX
0001285221
FOSTER ANDREW B
20400 STEVENS CREK BLVD, SUITE 700
CUPERTINO
CA
95014
false
true
false
false
Executive Vice President
Common Stock
2021-04-22
4
F
false
4683
18.58
D
23862
D
Common Stock
2021-04-19
4
F
false
10500
18.99
D
221404
D
Common Stock
2021-04-22
4
F
false
1350
18.58
D
32382
D
Common Stock
2021-04-19
4
F
false
9058
18.99
D
153404
D
Common Stock
2021-01-27
4
S
false
15000
7.77
D
5235
D
Common Stock
2021-01-28
4
S
false
10000
7.5517
D
5235
D
Common Stock
2021-01-29
4
S
false
10000
6.57
D
5235
D
Common Stock
2021-02-01
4
S
false
10000
7.91
D
5235
D
Common Stock
2021-02-02
4
S
false
5000
7.53
D
5235
D
Common Stock
2021-03-15
4
F
false
1681
20.83
D
53554
D
Common Stock
2021-02-02
4
S
false
5000
8
D
5235
D
Common Stock
2021-02-03
4
S
false
10000
7.53
D
5235
D
Common Stock
2021-02-04
4
S
false
10000
7.86
D
5235
D
Common Stock
2021-02-05
4
S
false
10000
7.45
D
5235
D
Common Stock
2021-02-08
4
S
false
10000
7.59
D
5235
D
Common Stock
2021-01-26
4
S
false
5000
9.0422
D
5235
D
Common Stock
2021-03-16
4
F
false
1112
19.21
D
90361
D
Common Stock
2021-04-19
4
F
false
1696
18.99
D
254708
D
Common Stock
2021-04-19
4
F
false
1887
18.99
D
45190
D
Common Stock
2021-03-15
4
F
false
1081
20.83
D
89973
D
Common Stock
2021-04-22
4
F
false
1664
18.58
D
40718
D
Common Stock
2021-01-25
4
S
false
10000
7.55
D
5235
D
Common Stock
2021-03-15
4
S
false
29000
19.9231
D
60973
D
Common Stock
2021-03-16
4
S
false
32800
19.5437
D
57561
D
Common Stock
2021-03-17
4
S
false
52150
18.9162
D
5411
D
Common Stock
2021-04-19
4
F
false
2728
18.99
D
62462
D
Common Stock
2021-04-19
4
S
false
236163
18.6479
D
18545
D
Common Stock
2021-04-20
4
S
false
10000
17.7075
D
8545
D
Common Stock
2021-04-22
4
S
false
32170
19.3969
D
8548
D
These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.
As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.
These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
These shares were sold pursuant to a Rule 10b5-1 plan.
/s/Todd Waltz attorney-infact
2021-10-21